Cargando…
Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization
Prescription of PCSK9-inhibitors has increased in recent years but not much is known about its off-target effects. PCSK9-expression is evident in non-hepatic tissues, notably the brain, and genetic variation in the PCSK9 locus has recently been shown to be associated with mood disorder-related trait...
Autores principales: | Aman, Alisha, Slob, Eric A. W., Ward, Joey, Cullen, Breda, Graham, Nicholas, Lyall, Donald M., Sattar, Naveed, Strawbridge, Rona J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799310/ https://www.ncbi.nlm.nih.gov/pubmed/36580462 http://dx.doi.org/10.1371/journal.pone.0279381 |
Ejemplares similares
-
Genetic analysis of the PCSK9 locus in psychological, psychiatric, metabolic and cardiovascular traits in UK Biobank
por: Hay, Rachel, et al.
Publicado: (2022) -
The association between C-reactive protein, mood disorder, and cognitive function in UK Biobank
por: Milton, David C., et al.
Publicado: (2021) -
PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
por: Lyall, Donald M., et al.
Publicado: (2021) -
Phenotypic and genetic associations between anhedonia and brain structure in UK Biobank
por: Zhu, Xingxing, et al.
Publicado: (2021) -
Consistent effects of the genetics of happiness across the lifespan and ancestries in multiple cohorts
por: Ward, Joey, et al.
Publicado: (2023)